XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Oct. 31, 2023 10,343,223      
Balance at Oct. 31, 2023 $ 104 $ 26,087 $ 13,571 $ 39,762
Stock-based compensation expense   744   744
Tax withholding related to vesting of restricted stock (in shares) 2,063      
Tax withholding related to vesting of restricted stock   (9)   (9)
Consolidated net income     (6,361) (6,361)
Balance (in shares) at Jul. 31, 2024 10,493,485      
Balance at Jul. 31, 2024 $ 105 26,821 7,210 34,136
Issuance of restricted stock (in shares) 152,325      
Issuance of restricted stock $ 1 (1) 0 0
Tax withholding related to vesting of restricted stock   9   9
Issuance of restricted stock (in shares) 152,325      
Issuance of restricted stock $ 1 (1) 0 0
Tax withholding related to vesting of restricted stock (in shares) (2,063)      
Balance (in shares) at Apr. 30, 2024 10,495,548      
Balance at Apr. 30, 2024 $ 105 26,589 7,915 34,609
Stock-based compensation expense   241   241
Tax withholding related to vesting of restricted stock (in shares) (2,063)      
Tax withholding related to vesting of restricted stock   (9)   (9)
Consolidated net income     (705) (705)
Balance (in shares) at Jul. 31, 2024 10,493,485      
Balance at Jul. 31, 2024 $ 105 26,821 7,210 34,136
Tax withholding related to vesting of restricted stock   9   9
Tax withholding related to vesting of restricted stock (in shares) 2,063      
Balance (in shares) at Oct. 31, 2024 10,544,431      
Balance at Oct. 31, 2024 $ 106 26,988 6,972 34,066
Stock-based compensation expense   640   640
Tax withholding related to vesting of restricted stock (in shares) (10,107)      
Tax withholding related to vesting of restricted stock   (43)   (43)
Consolidated net income     (98) (98)
Balance (in shares) at Jul. 31, 2025 10,667,447      
Balance at Jul. 31, 2025 $ 107 27,791 6,874 $ 34,772
Exercise of stock options (in shares) 50,623     50,623
Exercise of stock options $ 1 206   $ 207
Issuance of restricted stock (in shares) 82,500      
Issuance of restricted stock $ 0      
Issuance of restricted stock   0    
Tax withholding related to vesting of restricted stock   43   43
Issuance of restricted stock (in shares) 82,500      
Issuance of restricted stock $ 0      
Tax withholding related to vesting of restricted stock (in shares) 10,107      
Balance (in shares) at Apr. 30, 2025 10,668,653      
Balance at Apr. 30, 2025 $ 107 27,581 6,482 34,170
Stock-based compensation expense   219   219
Tax withholding related to vesting of restricted stock (in shares) (1,206)      
Tax withholding related to vesting of restricted stock   (9)   (9)
Consolidated net income     392 392
Balance (in shares) at Jul. 31, 2025 10,667,447      
Balance at Jul. 31, 2025 $ 107 27,791 $ 6,874 34,772
Tax withholding related to vesting of restricted stock   $ 9   $ 9
Tax withholding related to vesting of restricted stock (in shares) 1,206